{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T06:35:16Z","timestamp":1794983716359,"version":"4.9.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012669","name":"Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission","doi-asserted-by":"publisher","award":["CSTB2022NSCQ-MSX0548"],"award-info":[{"award-number":["CSTB2022NSCQ-MSX0548"]}],"id":[{"id":"10.13039\/501100012669","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-025-03823-w","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T14:04:21Z","timestamp":1751551461000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["HIF-1\u03b1 and HIF-2\u03b1: synergistic regulation of glioblastoma malignant progression during hypoxia and apparent chemosensitization in response to hyperbaric oxygen"],"prefix":"10.1186","volume":"25","author":[{"given":"Pan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"issue":"16","key":"3823_CR1","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1016\/j.cell.2022.06.054","volume":"185","author":"V Venkataramani","year":"2022","unstructured":"Venkataramani V, Yang Y, Schubert MC, Reyhan E, Tetzlaff SK, Wi\u00dfmann N, Botz M, Soyka SJ, Beretta CA, Pramatarov RL, et al. Glioblastoma hijacks neuronal mechanisms for brain invasion. Cell. 2022;185(16):2899\u2013917.","journal-title":"Cell"},{"issue":"8","key":"3823_CR2","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/neuonc\/noaa091","volume":"22","author":"TG Krieger","year":"2020","unstructured":"Krieger TG, Tirier SM, Park J, Jechow K, Eisemann T, Peterziel H, Angel P, Eils R, Conrad C. Modeling glioblastoma invasion using human brain organoids and single-cell transcriptomics. Neuro Oncol. 2020;22(8):1138\u201349.","journal-title":"Neuro Oncol"},{"issue":"8","key":"3823_CR3","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/s41582-018-0025-8","volume":"14","author":"ML Broekman","year":"2018","unstructured":"Broekman ML, Maas SLN, Abels ER, Mempel TR, Krichevsky AM, Breakefield XO. Multidimensional communication in the microenvirons of glioblastoma. Nat Rev Neurol. 2018;14(8):482\u201395.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"3823_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.trecan.2022.09.005","volume":"9","author":"A Bikfalvi","year":"2023","unstructured":"Bikfalvi A, da Costa CA, Avril T, Barnier JV, Bauchet L, Brisson L, Cartron PF, Castel H, Chevet E, Chneiweiss H, et al. Challenges in glioblastoma research: focus on the tumor microenvironment. Trends in cancer. 2023;9(1):9\u201327.","journal-title":"Trends in cancer"},{"issue":"7","key":"3823_CR5","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41419-024-06904-2","volume":"15","author":"J Bou-Gharios","year":"2024","unstructured":"Bou-Gharios J, No\u00ebl G, Burckel H. Preclinical and clinical advances to overcome hypoxia in glioblastoma multiforme. Cell Death Dis. 2024;15(7):503.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3823_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13046-020-01641-8","volume":"39","author":"J Liu","year":"2020","unstructured":"Liu J, Gao L, Zhan N, Xu P, Yang J, Yuan F, Xu Y, Cai Q, Geng R, Chen Q. Hypoxia induced ferritin light chain (FTL) promoted epithelia mesenchymal transition and chemoresistance of glioma. J Exp Clin Cancer Res. 2020;39(1):137.","journal-title":"J Exp Clin Cancer Res"},{"key":"3823_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216801","volume":"590","author":"M Dong","year":"2024","unstructured":"Dong M, Zhang X, Peng P, Chen Z, Zhang Y, Wan L, Xiang W, Liu G, Guo Y, Xiao Q, et al. Hypoxia-induced TREM1 promotes mesenchymal-like states of glioma stem cells via alternatively activating tumor-associated macrophages. Cancer Lett. 2024;590: 216801.","journal-title":"Cancer Lett"},{"issue":"1","key":"3823_CR8","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13045-021-01102-5","volume":"14","author":"XC Ding","year":"2021","unstructured":"Ding XC, Wang LL, Zhang XD, Xu JL, Li PF, Liang H, Zhang XB, Xie L, Zhou ZH, Yang J, et al. The relationship between expression of PD-L1 and HIF-1\u03b1 in glioma cells under hypoxia. J Hematol Oncol. 2021;14(1):92.","journal-title":"J Hematol Oncol"},{"issue":"12","key":"3823_CR9","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1158\/2159-8290.CD-22-0196","volume":"12","author":"L Wu","year":"2022","unstructured":"Wu L, Wu W, Zhang J, Zhao Z, Li L, Zhu M, Wu M, Wu F, Zhou F, Du Y, et al. Natural coevolution of tumor and immunoenvironment in glioblastoma. Cancer Discov. 2022;12(12):2820\u201337.","journal-title":"Cancer Discov"},{"issue":"6","key":"3823_CR10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ccr.2009.03.018","volume":"15","author":"Z Li","year":"2009","unstructured":"Li Z, Bao S, Wu Q, Wang H, Eyler C, Sathornsumetee S, Shi Q, Cao Y, Lathia J, McLendon RE, et al. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell. 2009;15(6):501\u201313.","journal-title":"Cancer Cell"},{"issue":"7","key":"3823_CR11","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1101\/gad.257394.114","volume":"29","author":"FM Kouri","year":"2015","unstructured":"Kouri FM, Hurley LA, Daniel WL, Day ES, Hua Y, Hao L, Peng CY, Merkel TJ, Queisser MA, Ritner C, et al. miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma. Genes Dev. 2015;29(7):732\u201345.","journal-title":"Genes Dev"},{"issue":"1","key":"3823_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagrm.2022.194900","volume":"1866","author":"N Kumar","year":"2023","unstructured":"Kumar N, Mondal M, Arathi BP, Sundaresan NR, Somasundaram K. Histone acetyltransferase 1 (HAT1) acetylates hypoxia-inducible factor 2 alpha (HIF2A) to execute hypoxia response. Biochim Biophys Acta. 2023;1866(1): 194900.","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"3823_CR13","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.3171\/2014.9.FOCUS14496","volume":"37","author":"M Womeldorff","year":"2014","unstructured":"Womeldorff M, Gillespie D, Jensen RL. Hypoxia-inducible factor-1 and associated upstream and downstream proteins in the pathophysiology and management of glioblastoma. Neurosurg Focus. 2014;37(6):E8.","journal-title":"Neurosurg Focus"},{"issue":"4","key":"3823_CR14","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41419-021-03598-8","volume":"12","author":"P Wang","year":"2021","unstructured":"Wang P, Zhao L, Gong S, Xiong S, Wang J, Zou D, Pan J, Deng Y, Yan Q, Wu N, et al. HIF1\u03b1\/HIF2\u03b1-Sox2\/Klf4 promotes the malignant progression of glioblastoma via the EGFR-PI3K\/AKT signalling pathway with positive feedback under hypoxia. Cell Death Dis. 2021;12(4):312.","journal-title":"Cell Death Dis"},{"issue":"11","key":"3823_CR15","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/s41419-020-03150-0","volume":"11","author":"P Wang","year":"2020","unstructured":"Wang P, Yan Q, Liao B, Zhao L, Xiong S, Wang J, Zou D, Pan J, Wu L, Deng Y, et al. The HIF1\u03b1\/HIF2\u03b1-miR210-3p network regulates glioblastoma cell proliferation, dedifferentiation and chemoresistance through EGF under hypoxic conditions. Cell Death Dis. 2020;11(11):992.","journal-title":"Cell Death Dis"},{"issue":"9","key":"3823_CR16","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.3390\/cancers15092613","volume":"15","author":"T Shi","year":"2023","unstructured":"Shi T, Zhu J, Zhang X, Mao X. The role of hypoxia and cancer stem cells in development of glioblastoma. Cancers (Basel). 2023;15(9):2613.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"3823_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/2045-9912.324589","volume":"12","author":"WJ Wang","year":"2022","unstructured":"Wang WJ, Ding JS, Sun Q, Xu X, Chen G. Role of hyperbaric oxygen in glioma: a narrative review. Med Gas Res. 2022;12(1):1\u20135.","journal-title":"Med Gas Res"},{"issue":"2","key":"3823_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s11060-007-9407-2","volume":"85","author":"LE Stuhr","year":"2007","unstructured":"Stuhr LE, Raa A, Oyan AM, Kalland KH, Sakariassen PO, Petersen K, Bjerkvig R, Reed RK. Hyperoxia retards growth and induces apoptosis, changes in vascular density and gene expression in transplanted gliomas in nude rats. J Neurooncol. 2007;85(2):191\u2013202.","journal-title":"J Neurooncol"},{"issue":"2","key":"3823_CR19","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.ijrobp.2010.12.070","volume":"82","author":"K Ogawa","year":"2012","unstructured":"Ogawa K, Ishiuchi S, Inoue O, Yoshii Y, Saito A, Watanabe T, Iraha S, Toita T, Kakinohana Y, Ariga T, et al. Phase II trial of radiotherapy after hyperbaric oxygenation with multiagent chemotherapy (procarbazine, nimustine, and vincristine) for high-grade gliomas: long-term results. Int J Radiat Oncol Biol Phys. 2012;82(2):732\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"3823_CR20","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1185\/03007995.2015.1082988","volume":"31","author":"JR Chen","year":"2015","unstructured":"Chen JR, Xu HZ, Ding JB, Qin ZY. Radiotherapy after hyperbaric oxygenation in malignant gliomas. Curr Med Res Opin. 2015;31(11):1977\u201384.","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"3823_CR21","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1093\/jrr\/rrw105","volume":"58","author":"K Yahara","year":"2017","unstructured":"Yahara K, Ohguri T, Udono H, Yamamoto J, Tomura K, Onoda T, Imada H, Nishizawa S, Korogi Y. Radiotherapy using IMRT boosts after hyperbaric oxygen therapy with chemotherapy for glioblastoma. J Radiat Res. 2017;58(3):351\u20136.","journal-title":"J Radiat Res"},{"issue":"3","key":"3823_CR22","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.radonc.2015.08.007","volume":"116","author":"J Kessler","year":"2015","unstructured":"Kessler J, G\u00fcttler A, Wichmann H, Rot S, Kappler M, Bache M, Vordermark D. IDH1(R132H) mutation causes a less aggressive phenotype and radiosensitizes human malignant glioma cells independent of the oxygenation status. Radiother Oncol. 2015;116(3):381\u20137.","journal-title":"Radiother Oncol"},{"issue":"10","key":"3823_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0165479","volume":"11","author":"L Lemaire","year":"2016","unstructured":"Lemaire L, Nel J, Franconi F, Bastiat G, Saulnier P. Perfluorocarbon-loaded lipid nanocapsules to assess the dependence of U87-human glioblastoma tumor pO2 on in vitro expansion conditions. PLoS ONE. 2016;11(10): e0165479.","journal-title":"PLoS ONE"},{"issue":"9","key":"3823_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042661","volume":"7","author":"L Ge","year":"2012","unstructured":"Ge L, Cornforth AN, Hoa NT, Delgado C, Chiou SK, Zhou YH, Jadus MR. Differential glioma-associated tumor antigen expression profiles of human glioma cells grown in hypoxia. PLoS ONE. 2012;7(9): e42661.","journal-title":"PLoS ONE"},{"key":"3823_CR25","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.semcancer.2022.12.011","volume":"88","author":"C Liao","year":"2023","unstructured":"Liao C, Liu X, Zhang C, Zhang Q. Tumor hypoxia: From basic knowledge to therapeutic implications. Semin Cancer Biol. 2023;88:172\u201386.","journal-title":"Semin Cancer Biol"},{"key":"3823_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.semcancer.2023.09.002","volume":"96","author":"GL Semenza","year":"2023","unstructured":"Semenza GL. Targeting intratumoral hypoxia to enhance anti-tumor immunity. Semin Cancer Biol. 2023;96:5\u201310.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"3823_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","volume":"18","author":"X Jing","year":"2019","unstructured":"Jing X, Yang F, Shao C, Wei K, Xie M, Shen H, Shu Y. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol Cancer. 2019;18(1):157.","journal-title":"Mol Cancer"},{"issue":"6","key":"3823_CR28","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1007\/s00259-020-04706-0","volume":"47","author":"A Leimgruber","year":"2020","unstructured":"Leimgruber A, Hickson K, Lee ST, Gan HK, Cher LM, Sachinidis JI, O\u2019Keefe GJ, Scott AM. Spatial and quantitative mapping of glycolysis and hypoxia in glioblastoma as a predictor of radiotherapy response and sites of relapse. Eur J Nucl Med Mol Imaging. 2020;47(6):1476\u201385.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"3823_CR29","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.7150\/thno.81407","volume":"13","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Zhang B, Lv C, Zhang N, Xing K, Wang Z, Lv R, Yu M, Xu C, Wang Y. Single-cell RNA sequencing identifies critical transcription factors of tumor cell invasion induced by hypoxia microenvironment in glioblastoma. Theranostics. 2023;13(11):3744\u201360.","journal-title":"Theranostics"},{"key":"3823_CR30","doi-asserted-by":"publisher","first-page":"16105","DOI":"10.1038\/cddiscovery.2016.105","volume":"3","author":"P Wang","year":"2017","unstructured":"Wang P, Wan WW, Xiong SL, Feng H, Wu N. Cancer stem-like cells can be induced through dedifferentiation under hypoxic conditions in glioma, hepatoma and lung cancer. Cell Death Discov. 2017;3:16105.","journal-title":"Cell Death Discov"},{"issue":"18","key":"3823_CR31","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.4155\/fmc-2018-0163","volume":"10","author":"JJ Renfrow","year":"2018","unstructured":"Renfrow JJ, Soike MH, Debinski W, Ramkissoon SH, Mott RT, Frenkel MB, Sarkaria JN, Lesser GJ, Strowd RE. Hypoxia-inducible factor 2\u03b1: a novel target in gliomas. Fut Med Chem. 2018;10(18):2227\u201336.","journal-title":"Fut Med Chem"},{"issue":"1","key":"3823_CR32","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/s12967-024-05218-3","volume":"22","author":"J Bai","year":"2024","unstructured":"Bai J, Zhao Y, Shi K, Fan Y, Ha Y, Chen Y, Luo B, Lu Y, Jie W, Shen Z. HIF-1\u03b1-mediated LAMC1 overexpression is an unfavorable predictor of prognosis for glioma patients: evidence from pan-cancer analysis and validation experiments. J Transl Med. 2024;22(1):391.","journal-title":"J Transl Med"},{"issue":"7","key":"3823_CR33","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/s41374-021-00664-9","volume":"102","author":"YP Li","year":"2022","unstructured":"Li YP, Liu Y, Xiao LM, Chen LK, Tao EX, Zeng EM, Xu CH. Induction of cancer cell stemness in glioma through glycolysis and the long noncoding RNA HULC-activated FOXM1\/AGR2\/HIF-1\u03b1 axis. Lab Investig. 2022;102(7):691\u2013701.","journal-title":"Lab Investig"},{"issue":"8","key":"3823_CR34","doi-asserted-by":"publisher","first-page":"887","DOI":"10.2217\/nnm-2017-0395","volume":"13","author":"Y Xie","year":"2018","unstructured":"Xie Y, Zeng X, Wu X, Hu J, Zhu Y, Yang X. Hyperbaric oxygen as an adjuvant to temozolomide nanoparticle inhibits glioma growth by inducing G2\/M phase arrest. Nanomedicine (Lond). 2018;13(8):887\u201398.","journal-title":"Nanomedicine (Lond)"},{"issue":"23","key":"3823_CR35","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.4103\/0366-6999.170278","volume":"128","author":"JB Ding","year":"2015","unstructured":"Ding JB, Chen JR, Xu HZ, Qin ZY. Effect of hyperbaric oxygen on the growth of intracranial glioma in rats. Chin Med J (Engl). 2015;128(23):3197\u2013203.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"3823_CR36","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3892\/ol.2015.3244","volume":"10","author":"YG Wang","year":"2015","unstructured":"Wang YG, Zhan YP, Pan SY, Wang HD, Zhang DX, Gao K, Qi XL, Yu CJ. Hyperbaric oxygen promotes malignant glioma cell growth and inhibits cell apoptosis. Oncol Lett. 2015;10(1):189\u201395.","journal-title":"Oncol Lett"},{"key":"3823_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.886603","volume":"13","author":"D Alpuim Costa","year":"2022","unstructured":"Alpuim Costa D, Sampaio-Alves M, Netto E, Fernandez G, Oliveira E, Teixeira A, Daniel PM, Bernardo GS, Amaro C. Hyperbaric oxygen therapy as a complementary treatment in glioblastoma\u2014a scoping review. Front Neurol. 2022;13: 886603.","journal-title":"Front Neurol"},{"issue":"5","key":"3823_CR38","first-page":"2703","volume":"41","author":"K Zembrzuska","year":"2019","unstructured":"Zembrzuska K, Ostrowski RP, Matyja E. Hyperbaric oxygen increases glioma cell sensitivity to antitumor treatment with a novel isothiourea derivative in vitro. Oncol Rep. 2019;41(5):2703\u201316.","journal-title":"Oncol Rep"},{"key":"3823_CR39","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.canlet.2021.02.019","volume":"506","author":"C Arienti","year":"2021","unstructured":"Arienti C, Pignatta S, Zanoni M, Zamagni A, Cortesi M, Sarnelli A, Romeo A, Arpa D, Longobardi P, Bartolini D, et al. High-pressure oxygen rewires glucose metabolism of patient-derived glioblastoma cells and fuels inflammasome response. Cancer Lett. 2021;506:152\u201366.","journal-title":"Cancer Lett"},{"issue":"6","key":"3823_CR40","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00066-024-02220-y","volume":"200","author":"T Xie","year":"2024","unstructured":"Xie T, Ding YH, Sang CS, Lin ZX, Dong J, Fu XA. Vitexin enhances radiosensitivity of mouse subcutaneous xenograft glioma by affecting the miR-17-5p\/miR-130b-3p\/PTEN\/HIF-1\u03b1 pathway. Strahlenther Onkol. 2024;200(6):535\u201343.","journal-title":"Strahlenther Onkol"},{"issue":"3","key":"3823_CR41","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/1878-0261.13735","volume":"19","author":"U Shahzad","year":"2025","unstructured":"Shahzad U, Nikolopoulos M, Li C, Johnston M, Wang JJ, Sabha N, Varn FS, Riemenschneider A, Krumholtz S, Krishnamurthy PM, et al. CASCADES, a novel SOX2 super-enhancer-associated long noncoding RNA, regulates cancer stem cell specification and differentiation in glioblastoma. Mol Oncol. 2025;19(3):764\u201384.","journal-title":"Mol Oncol"},{"issue":"12","key":"3823_CR42","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1093\/neuonc\/noaa138","volume":"22","author":"LH Zhang","year":"2020","unstructured":"Zhang LH, Yin YH, Chen HZ, Feng SY, Liu JL, Chen L, Fu WL, Sun GC, Yu XG, Xu DG. TRIM24 promotes stemness and invasiveness of glioblastoma cells via activating Sox2 expression. Neuro Oncol. 2020;22(12):1797\u2013808.","journal-title":"Neuro Oncol"},{"issue":"11","key":"3823_CR43","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1007\/BF01209031","volume":"122","author":"K Kohshi","year":"1996","unstructured":"Kohshi K, Kinoshita Y, Terashima H, Konda N, Yokota A, Soejima T. Radiotherapy after hyperbaric oxygenation for malignant gliomas: a pilot study. J Cancer Res Clin Oncol. 1996;122(11):676\u20138.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"3823_CR44","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11060-018-03021-x","volume":"141","author":"Y Aghajan","year":"2019","unstructured":"Aghajan Y, Grover I, Gorsi H, Tumblin M, Crawford JR. Use of hyperbaric oxygen therapy in pediatric neuro-oncology: a single institutional experience. J Neurooncol. 2019;141(1):151\u20138.","journal-title":"J Neurooncol"},{"issue":"2","key":"3823_CR45","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1023\/A:1022169107872","volume":"61","author":"T Beppu","year":"2003","unstructured":"Beppu T, Kamada K, Nakamura R, Oikawa H, Takeda M, Fukuda T, Arai H, Ogasawara K, Ogawa A. A phase II study of radiotherapy after hyperbaric oxygenation combined with interferon-beta and nimustine hydrochloride to treat supratentorial malignant gliomas. J Neurooncol. 2003;61(2):161\u201370.","journal-title":"J Neurooncol"},{"issue":"7","key":"3823_CR46","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1007\/s12094-019-02234-4","volume":"22","author":"T Xie","year":"2020","unstructured":"Xie T, Wang JR, Dai CG, Fu XA, Dong J, Huang Q. Vitexin, an inhibitor of hypoxia-inducible factor-1\u03b1, enhances the radiotherapy sensitization of hyperbaric oxygen on glioma. Clin Transl Oncol. 2020;22(7):1086\u201393.","journal-title":"Clin Transl Oncol"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03823-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-025-03823-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03823-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T14:40:51Z","timestamp":1751553651000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-025-03823-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3823"],"URL":"https:\/\/doi.org\/10.1186\/s12935-025-03823-w","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]},"assertion":[{"value":"22 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The collection of primary GBM tissues was approved by the Ethics Committee of Chongqing General Hospital (No. KY S2022-094\u201301), and informed consent was obtained from the patients. The animal procedures were approved by the Ethics Committee of ChongQing Medical University (No. IACUC-CQMU-2023\u20130167).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"251"}}